BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 38500550)

  • 1. MAPK15 controls cellular responses to oxidative stress by regulating NRF2 activity and expression of its downstream target genes.
    Franci L; Vallini G; Bertolino FM; Cicaloni V; Inzalaco G; Cicogni M; Tinti L; Calabrese L; Barone V; Salvini L; Rubegni P; Galvagni F; Chiariello M
    Redox Biol; 2024 Jun; 72():103131. PubMed ID: 38555711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Nrf2 signaling pathways in the role of bladder cancer: From signal network to targeted therapy.
    Wu L; Hu Z; Song XF; Liao YJ; Xiahou JH; Li Y; Zhang ZH
    Biomed Pharmacother; 2024 May; 176():116829. PubMed ID: 38820972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?
    Wang R; Liang L; Matsumoto M; Iwata K; Umemura A; He F
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 protein in melanoma progression, as a new means of treatment.
    Feng Q; Xu X; Zhang S
    Pigment Cell Melanoma Res; 2024 Mar; 37(2):247-258. PubMed ID: 37777339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACA-28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells.
    Takasaki T; Hamabe Y; Touchi K; Khandakar GI; Ueda T; Okada H; Sakai K; Nishio K; Tanabe G; Sugiura R
    Oxid Med Cell Longev; 2024; 2024():7683793. PubMed ID: 38500550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis.
    Tian H; Zhang D; Gao Z; Li H; Zhang B; Zhang Q; Li L; Cheng Q; Pei D; Zheng J
    Cancer Gene Ther; 2014 Oct; 21(10):416-26. PubMed ID: 25236495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa pyocyanin activates NRF2-ARE-mediated transcriptional response via the ROS-EGFR-PI3K-AKT/MEK-ERK MAP kinase signaling in pulmonary epithelial cells.
    Xu Y; Duan C; Kuang Z; Hao Y; Jeffries JL; Lau GW
    PLoS One; 2013; 8(8):e72528. PubMed ID: 24015256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK inhibition sensitizes cancer cells to oleanolic acid-induced apoptosis through ERK/Nrf2/ROS pathway.
    Liu J; Ma L; Chen X; Wang J; Yu T; Gong Y; Ma A; Zheng L; Liang H
    Tumour Biol; 2016 Jun; 37(6):8181-7. PubMed ID: 26715278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of HO-1 by Nrf2 activation protects against palmitic acid-induced ROS increase in human neuroblastoma BE(2)-M17 cells.
    Shi Y; Sun Y; Sun X; Zhao H; Yao M; Hou L; Jiang L
    Nutr Res; 2018 Apr; 52():80-86. PubMed ID: 29526395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoprotective effects of 7,8-dihydroxyflavone against oxidative stress are mediated by the upregulation of Nrf2-dependent HO-1 expression through the activation of the PI3K/Akt and ERK pathways in C2C12 myoblasts.
    Kang JS; Choi IW; Han MH; Kim GY; Hong SH; Park C; Hwang HJ; Kim CM; Kim BW; Choi YH
    Int J Mol Med; 2015 Aug; 36(2):501-10. PubMed ID: 26096841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials.
    Song Y; Bi Z; Liu Y; Qin F; Wei Y; Wei X
    Genes Dis; 2023 Jan; 10(1):76-88. PubMed ID: 37013062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca-2 Cells.
    Khandakar GI; Satoh R; Takasaki T; Fujitani K; Tanabe G; Sakai K; Nishio K; Sugiura R
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.
    Sugiura R; Satoh R; Takasaki T
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive oxygen species in cancer: Current findings and future directions.
    Nakamura H; Takada K
    Cancer Sci; 2021 Oct; 112(10):3945-3952. PubMed ID: 34286881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U0126 pretreatment inhibits cisplatin-induced apoptosis and autophagy in HEI-OC1 cells and cochlear hair cells.
    Wang D; Shi S; Ren T; Zhang Y; Guo P; Wang J; Wang W
    Toxicol Appl Pharmacol; 2021 Mar; 415():115447. PubMed ID: 33577918
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.